Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' NABAVI N' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 31 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bemben, DA; Fetters, NL; Bemben, MG; Nabavi, N; Koh, ET
      Musculoskeletal responses to high- and low-intensity resistance training in early postmenopausal women

      MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
    2. COLE DJ; GATTONICELLI S; MCCLAY EF; METCALF JS; BROWN JM; NABAVI N; NEWTON DA; WOOLHISER CB; WILSON MC; VOURNAKIS JN
      CHARACTERIZATION OF A SUSTAINED-RELEASE DELIVERY SYSTEM FOR COMBINED CYTOKINE PEPTIDE VACCINATION USING A POLY-N-ACETYL GLUCOSAMINE-BASED POLYMER MATRIX/

      Clinical cancer research
    3. BEMBEN D; BEMBEN M; FETTERS N; NABAVI N
      BODY-WEIGHT AND HIP ABDUCTOR STRENGTH PREDICT HIP BONE-MINERAL DENSITY IN EARLY POSTMENOPAUSAL WOMEN

      Journal of aging and physical activity
    4. GUBLER U; PRESKY D; MINETTI L; CHUA A; YANG H; NABAVI N; GATELY M
      MOLECULAR CHARACTERIZATION OF INTERLEUKIN-12 RECEPTORS

      The FASEB journal
    5. PRESKY DH; YANG H; MINETTI LJ; CHUA AO; NABAVI N; WU CY; GATELY MK; GUBLER U
      A FUNCTIONAL INTERLEUKIN-12 RECEPTOR COMPLEX IS COMPOSED OF 2 BETA-TYPE CYTOKINE RECEPTOR SUBUNITS

      Proceedings of the National Academy of Sciences of the United Statesof America
    6. BROWN JA; TITUS RG; NABAVI N; GLIMCHER LH
      BLOCKADE OF CD86 AMELIORATES LEISHMANIA-MAJOR INFECTION BY DOWN-REGULATING THE TH2 RESPONSE

      The Journal of infectious diseases
    7. BASKAR S; CLEMENTS VK; GLIMCHER LH; NABAVI N; OSTRANDROSENBERG S
      REJECTION OF MHC CLASS II-TRANSFECTED TUMOR-CELLS REQUIRES INDUCTION OF TUMOR-ENCODED B7-1 AND OR B7-2 COSTIMULATORY MOLECULES/

      The Journal of immunology
    8. MARTINFONTECHA A; CAVALLO F; BELLONE M; HELTAI S; IEZZI G; TORNAGHI P; NABAVI N; FORNI G; DELLABONA P; CASORATI G
      HETEOGENEOUS OF B7-1 AND B7-2 IN THE INDUCTION OF BOTH PROTECTIVE ANDTHERAPEUTIC ANTITUMOR IMMUNITY AGAINST DIFFERENT MOUSE-TUMORS

      European Journal of Immunology
    9. CAI YC; CEFAI D; SCHNEIDER H; RAAB M; NABAVI N; RUDD CE
      SELECTIVE CD28PYMNM MUTATIONS IMPLICATE PHOSPHATIDYLINOSITOL 3-KINASEIN CD86-CD28-MEDIATED COSTIMULATION

      Immunity
    10. FLORES I; SARKAR S; DEROSA C; OZZELLO L; NABAVI N; SHEN YR; RON Y; PESTKA S
      IFN-GAMMA AND B7 AS COSTIMULATORS OF ANTITUMOR IMMUNE-RESPONSES

      International journal of oncology
    11. CHAVIN K; WOODWARD J; BAYER A; NABAVI N; BALIGA P
      IN-VIVO BLOCKADE OF T-CELL COSTIMULATION VIA ANTI-CD28 LIGAND MONOCLONAL-ANTIBODIES PROLONGS ALLOGRAFT SURVIVAL AND ALTERS CELL-MEDIATED-IMMUNITY

      The FASEB journal
    12. LENSCHOW DJ; RHEE L; NABAVI N; GRAY G; HEROLD KC; BLUESTONE JA
      DIFFERENTIAL ROLES OF THE B7-1 AND B7-2 COSTIMULATORY MOLECULES IN THE PATHOGENESIS OF AUTOIMMUNE DIABETES

      Journal of cellular biochemistry
    13. OSTRANDROSENBERG S; BASKAR S; GLIMCHER L; NABAVI N
      MHC CLASS-II B(-1+ TUMOR-CELLS ARE POTENT VACCINES FOR STIMULATING TUMOR REJECTION IN TUMOR-BEARING MICE()7)

      Journal of cellular biochemistry
    14. KUCHROO VK; DAS MP; BROWN JA; RANGER AM; ZAMVIL SS; SOBEL RA; WEINER HL; NABAVI N; GLIMCHER LH
      B7-1 AND B7-2 COSTIMULATORY MOLECULES ACTIVATE DIFFERENTIALLY THE TH1TH2 DEVELOPMENTAL PATHWAYS - APPLICATION TO AUTOIMMUNE-DISEASE THERAPY/

      Cell
    15. LENSCHOW DJ; HO SC; SATTAR H; RHEE L; GRAY G; NABAVI N; HEROLD KC; BLUESTONE JA
      DIFFERENTIAL-EFFECTS OF ANTI-B7-1 AND ANTI-B7-2 MONOCLONAL-ANTIBODY TREATMENT ON THE DEVELOPMENT OF DIABETES IN THE NONOBESE DIABETIC MOUSE

      The Journal of experimental medicine
    16. BASKAR S; GLIMCHER L; NABAVI N; JONES RT; OSTRANDROSENBERG S
      MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II(-1(+) TUMOR-CELLS ARE POTENT VACCINES FOR STIMULATING TUMOR REJECTION IN TUMOR-BEARING MICE()B7)

      The Journal of experimental medicine
    17. CHEN CY; NABAVI N
      IN-VITRO INDUCTION OF T-CELL ANERGY BY BLOCKING B7 AND EARLY T-CELL COSTIMULATORY MOLECULE ETC-1 B7-2

      Immunity
    18. CHEN C; GAULT A; NABAVI N
      IN-VITRO INDUCTION OF T-CELL ANERGY BY BLOCKING AN EARLY T-CELL COSTIMULATORY MOLECULE (ETC-1 B7-2) AND B7/

      The FASEB journal
    19. CHEN C; GAULT A; NABAVI N
      THE ROLE OF 2D10 MOLECULE IN T-CELL ACTIVATION AND ANERGY

      Journal of cellular biochemistry
    20. FAHERTY DA; KOLINSKY K; CONNAUGHTON S; NABAVI N
      IN-VIVO ACTIVITY OF MONOCLONAL-ANTIBODIES AGAINST MURINE B7 (1G10) AND A 2ND COSTIMULATORY MOLECULE (2D10)

      Journal of cellular biochemistry
    21. CHEN CY; FAHERTY DA; GAULT A; CONNAUGHTON SE; POWERS GD; GODFREY DI; NABAVI N
      MONOCLONAL-ANTIBODY 2D10 RECOGNIZES A NOVEL T-CELL COSTIMULATORY MOLECULE ON ACTIVATED MURINE B-LYMPHOCYTES

      The Journal of immunology
    22. CHEN CY; GAULT A; SHEN LJ; NABAVI N
      MOLECULAR-CLONING AND EXPRESSION OF EARLY T-CELL COSTIMULATORY MOLECULE-1 AND ITS CHARACTERIZATION AS B7-2 MOLECULE

      The Journal of immunology
    23. DEBECKER G; SORNASSE T; NABAVI N; BAZIN H; TIELEMANS F; URBAIN J; LEO O; MOSER M
      IMMUNOGLOBULIN ISOTYPE REGULATION BY ANTIGEN-PRESENTING CELLS IN-VIVO

      European Journal of Immunology
    24. POWERS GD; FAHERTY DA; CONNAUGHTON SE; BIONDI DA; GODFREY DI; GAULT A; CHEN CY; NABAVI N
      EXPRESSION AND FUNCTIONAL-ANALYSIS OF MURINE B7 DELINEATED BY A NOVELMONOCLONAL-ANTIBODY

      Cellular immunology
    25. BASKAR S; NABAVI N; GLIMCHER LH; OSTRANDROSENBERG S
      TUMOR-CELLS EXPRESSING MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II AND B7 ACTIVATION MOLECULES STIMULATE POTENT TUMOR-SPECIFIC IMMUNITY

      Journal of immunotherapy with emphasis on tumor immunology
    26. SINGER GG; YOKOYAMA H; BLOOM RD; JEVNIKAR AM; NABAVI N; KELLEY VR
      STIMULATED RENAL TUBULAR EPITHELIAL-CELLS INDUCE ANERGY IN CD4-CELLS(T)

      Kidney international
    27. LENSCHOW DJ; SU GHT; ZUCKERMAN LA; NABAVI N; JELLIS CL; GRAY GS; MILLER J; BLUESTONE JA
      EXPRESSION AND FUNCTIONAL-SIGNIFICANCE OF AN ADDITIONAL LIGAND FOR CTLA-4

      Proceedings of the National Academy of Sciences of the United Statesof America
    28. BASKAR S; OSTRANDROSENBERG S; NABAVI N; NADLER LM; FREEMAN GJ; GLIMCHER LH
      CONSTITUTIVE EXPRESSION OF B7 RESTORES IMMUNOGENICITY OF TUMOR-CELLS EXPRESSING TRUNCATED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES

      Proceedings of the National Academy of Sciences of the United Statesof America
    29. BASKAR S; OSTRANDROSENBERG S; NABAVI N; NADLER L; FREEMAN G; GLIMCHER L
      CONSTITUTIVE EXPRESSION OF B7 RESTORES IMMUNOGENICITY OF AUTOLOGOUS TUMOR-CELLS

      The Journal of immunology
    30. CHEN C; FAHERTY D; GAULT A; NABAVI N
      COSTIMULATORY MOLECULES OTHER THAN B7 ON ACTIVATED MURINE B-LYMPHOCYTES

      The Journal of immunology
    31. FAHERTY D; CONNAUGHTON S; KOLINSKY K; POWERS G; NABAVI N
      ACTIVITY OF A NOVEL ANTIBODY (1G10) AGAINST THE MURINE B7 MOLECULE INCELLULAR IMMUNE-RESPONSE MODELS

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 11:41:22